[1]
Paul, J. 2018. Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease. Journal of Neuroscience and Neurological Disorders. 2, 2 (Oct. 2018), 047–051. DOI:https://doi.org/10.29328/journal.jnnd.1001014.